Evidence map›Paper›PMID 23283495›Full record

ReviewStem cells translational medicine2013

Concise review: in search of unlimited sources of functional human pancreatic beta cells.

Raphael Scharfmann, Latif Rachdi, Philippe Ravassard

Open access · goldAbstract readReview
In one paragraph

Review in Stem cells translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The supply chain of human pancreatic β cell lines.The Journal of clinical investigation · 2019
    Review
  7. Article
  8. Dynamics of Insulin Secretion from EndoC-Journal of diabetes research · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Co-Culture of α TC-6 Cells and β TC-1 Cells: Morphology and Function.Endocrinology and metabolism (Seoul, Korea) · 2015
    Article
  14. Article
  15. In search of a surrogate: engineering human beta cell lines for therapy.Trends in endocrinology and metabolism: TEM · 2014
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Raphael ScharfmannParis Descartes University, Paris, France. raphael.scharfmann@inserm.fr
Latif Rachdi
Philippe Ravassard
Inserm · FRSorbonne Université · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well-established that insulin-producing pancreatic beta cells are central in diabetes. In type 1 diabetes, beta cells are destroyed by an autoimmune mechanism, whereas in type 2 diabetes, there is a decrease in functional beta-cell mass. In this context, studying beta cells is of major importance. Beta cells represent only 1% of total pancreatic cells and are found dispersed in the pancreatic gland. During the past decades, many tools and approaches have been developed to study rodent beta cells that efficiently pushed the field forward. However, rodent and human beta cells are not identical, and our knowledge of human beta cells has not progressed as quickly as our understanding of rodent beta cells. We believe that one of the reasons for this inefficient progress is the difficulty of accessing unlimited sources of functional human pancreatic beta cells. The main focus of this review concerns recent strategies to generate new sources of human pancreatic beta cells.

Indexed as

AnimalsCell DifferentiationCells, CulturedDiabetes MellitusHumansInduced Pluripotent Stem CellsInsulinInsulin-Secreting CellsInsulin SecretionPancreasRegenerative MedicineInsulin

Identifiers

PMID23283495
PMCPMC3659747
OpenAlexW2049583639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.